Page last updated: 2024-10-28

gr 89696 and Nervous System Diseases

gr 89696 has been researched along with Nervous System Diseases in 1 studies

GR 89696: a potent & selective kappa opioid receptor agonist; RN given refers to (E)-2-butenedioate(1:1); RN for parent cpd not available 11/92; GR 103545 is the (R)-isomer

Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.

Research Excerpts

ExcerptRelevanceReference
" In these experiments GR89696 was dosed 5 min, 4, 8, 12, 16, 20 and 24 h after occlusion on the first day and then three times daily for the next three days."1.28Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. ( Birch, PJ; Hayes, AG; Hayward, NJ; Judd, DB; Naylor, A; Rogers, H; Scopes, DI; Tyers, MB, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birch, PJ1
Rogers, H1
Hayes, AG1
Hayward, NJ1
Tyers, MB1
Scopes, DI1
Naylor, A1
Judd, DB1

Other Studies

1 other study available for gr 89696 and Nervous System Diseases

ArticleYear
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
    British journal of pharmacology, 1991, Volume: 103, Issue:3

    Topics: Animals; Brain Ischemia; Carotid Artery Diseases; Dizocilpine Maleate; Dose-Response Relationship, D

1991